Critical peritonitis secondary to gastrointestinal mucormycosis in a peritoneal dialysis patient: a case report

Soken Hattori1, Takashi Matono2, Makoto Hirakawa3

  • 1Department of Nephrology, Aso Iizuka Hospital, 3-83 Yoshio-machi, Iizuka, Fukuoka, 820-8505, Japan. shattorih1@aih-net.com.

CEN Case Reports
|July 17, 2021
PubMed

Insights

A rare case of gastrointestinal mucormycosis led to peritonitis in an immunocompromised patient on continuous ambulatory peritoneal dialysis (CAPD). Early diagnosis and consideration of risk factors like corticosteroid use are crucial for better outcomes.

Area of Science:

  • Medical Mycology
  • Gastroenterology
  • Nephrology

Background:

  • Immunocompromised patients are prone to systemic fungal infections.
  • Peritonitis is a rare complication of systemic fungal infections, especially in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
  • Risk factors for mucormycosis include corticosteroid use, diabetes mellitus, and end-stage kidney disease.

Observation:

  • A 66-year-old man with multiple myeloma, diabetes, and on CAPD presented with peritonitis.
  • Initial diagnosis was CAPD-related peritonitis caused by Enterococcus avium.
  • CT scans revealed a gastric mass and ascending colon wall thinning, later showing perforation and arterial rupture.

Findings:

  • Emergency surgery revealed hemorrhagic infarction with mucormycosis.
  • The patient received ampicillin and later liposomal amphotericin B.
  • Despite treatment, the patient died 55 days after admission.

Implications:

  • Gastrointestinal perforation should be considered in immunocompromised patients with peritonitis.
  • Gastrointestinal mucormycosis is a rare but often fatal condition, emphasizing the need for early diagnosis.
  • Identifying patients with risk factors for mucormycosis is essential for timely intervention and improved clinical outcomes.

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...